FIELD: medicine.
SUBSTANCE: there are described new p38 kinase inhibitors that are compounds of general formula (I) 
(radical values are presented in the patent claim), their pharmaceutically acceptable salts and solvates, a pharmaceutical composition containing thereof, and method for treating inflammatory diseases.
EFFECT: new compounds have effective biological activity.
24 cl, 311 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR CCR5 | 2005 |
|
RU2368608C2 |
| PIPERIDINE DERIVATIVES AS MODULATORS OF ACTIVITY OF CCR5 RECEPTOR, METHOD AND INTERMEDIATE COMPOUNDS FOR OBTAINING THEM, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2002 |
|
RU2345990C2 |
| SUBSTITUTED QUINAZINE DERIVATIVES AS FGFR-KINASE INHIBITORS FOR TREATMENT OF CANCER | 2011 |
|
RU2602233C2 |
| OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2719422C2 |
| NEW COMPOUND STIMULATORS OF GROWTH HORMONE SECRETION | 2003 |
|
RU2382042C2 |
| QUINAZOLINONE DERIVATIVES APPLICABLE AS MODULATORS OF FGFR KINASE | 2014 |
|
RU2701517C2 |
| USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
| PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
| HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2010 |
|
RU2558141C2 |
